![Sung Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sung Lee
Direttore Finanziario/CFO presso
CYTOKINETICS, INCORPORATED
Patrimonio netto: 6 M $ in data 30/06/2026
Profilo
Sung H.
Lee is currently Lead Independent Director at Tango Therapeutics, Inc. since 2026 and Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. since 2024.
Former positions include Vice President-Investor Relations at Gilead Sciences, Inc. from 2016 to 2019, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, Chief Financial Officer at MorphoSys AG from 2021 to 2023, and Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. from 2023 to 2024.
Education includes graduate studies at the University of Southern California and undergraduate studies at the University of California, Irvine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/07/2026 | 63.221 ( 0,05% ) | 5 M $ | 30/06/2026 | |
| 05/06/2026 | 22.870 ( 0,02% ) | 714 916 $ | 30/06/2026 |
Posizioni attive di Sung Lee
| Società | Posizione | Inizio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Direttore Finanziario/CFO | 08/05/2024 |
| TANGO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 05/01/2026 |
Precedenti posizioni note di Sung Lee
| Società | Posizione | Fine |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Direttore Finanziario/CFO | 03/05/2024 |
| MORPHOSYS AG | Direttore Finanziario/CFO | 17/03/2023 |
| SANGAMO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/02/2021 |
| GILEAD SCIENCES, INC. | Contatto Relazioni con gli Investitori | 31/10/2019 |
Formazione di Sung Lee
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
67
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
